Provided by Tiger Trade Technology Pte. Ltd.

BRII-B

1.470
0.000
Volume:- -
Turnover:- -
Market Cap:1.06B
PE:-1.87
High:1.470
Open:1.470
Low:1.470
Close:1.470
52wk High:3.090
52wk Low:1.080
Shares:722.00M
HK Float Shares:722.00M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.785
ROE:-14.42%
ROA:-8.42%
PB:0.38
PE(LYR):-1.87
PS:32.72

Loading ...

Brii Biosciences (02137) Issues Monthly Return for January 2026

Bulletin Express
·
Feb 04

BRIEF-Brii Biosciences And OpenBench Announce AI-Driven Collaboration For Proprietary Technology Platform

Reuters
·
Dec 11, 2025

Brii Biosciences and Openbench Announce AI-Driven Collaboration for Proprietary Technology Platform

THOMSON REUTERS
·
Dec 11, 2025

Openbench - Collaboration May Expand to Include Additional Programs

THOMSON REUTERS
·
Dec 11, 2025

Openbench - to Receive Payment for Delivering Novel Leads That Meet Specific Criteria Defined by Brii Bio

THOMSON REUTERS
·
Dec 11, 2025

Openbench - Brii Bio to Gain Exclusive Rights to Leads and Co's Technology

THOMSON REUTERS
·
Dec 11, 2025

HK Movers | Biotech Stocks Rise. Ascletis up 9%; Antengene up over 5%; Remegen, Laekna, Akeso, Hua Medicine up About 4%

Tiger Newspress
·
Dec 04, 2025

Brii Biosciences (02137) Releases Monthly Return for November 2025

Bulletin Express
·
Dec 03, 2025

HK Movers | Biotech Stocks Fall. Ascletis-B down 11%; Hua Medicine-B, Mabpharm-B down about 7%; Antengene-B down 5%; Ascentage-B down 4%.

Tiger Newspress
·
Dec 03, 2025

HK Pharma Shares Gained. CSPC Pharma Up 7%; 3SBio Up 6%; Remegen Up 4%; Sino Biopharm, Junshi Bio And Hengrui Pharma Up 3%

Tiger Newspress
·
Nov 26, 2025

HK Movers|Biotech Shares Gained. 3SBio And Hengrui Pharma Up 5%; Tigermed Up 3%; SKB Bio, JW Therap, Remegen And Wuxi XDC Up 2%

Tiger Newspress
·
Nov 24, 2025

Hong Kong Stocks Movement | Biotech Concept Stocks Lead Declines as BD Deals Cool and Rate Cut Expectations Fade

Stock News
·
Nov 21, 2025

Brii Biosciences Limited (Stock Code: 2137) Announces Revised Nomination Committee Terms

Bulletin Express
·
Nov 16, 2025

Brii Biosciences (2137) Presents Phase 2 ENSURE Study Results at AASLD 2025

Bulletin Express
·
Nov 10, 2025

BRII-B (02137) Presents Breakthrough Phase II ENSURE Study Data at 2025 AASLD Conference

Stock News
·
Nov 10, 2025

Brii Biosciences Reports Positive Phase 2 ENSURE Study Results for Hepatitis B Therapy

Reuters
·
Nov 10, 2025

Brii Biosciences (Stock Code: 2137) Publishes Phase 2 ENSURE Study Results in Nature Medicine

Bulletin Express
·
Nov 07, 2025

BRII-B (02137): ENSURE Phase II Study Results Published in Nature Medicine

Stock News
·
Nov 07, 2025

Brii Biosciences Reports Phase 2 ENSURE Study Results on HBV Cure Strategy in Nature Medicine

Reuters
·
Nov 07, 2025

Brii Biosciences (02137) Announces 613,412-Share Increase in October 2025

Bulletin Express
·
Nov 05, 2025